About UsNewsShop
Fighting hereditary breast and ovarian cancer
Information & Research
| More

PARP Inhibitors

  • Basics

Update: PARP Inhibitor Research
Article from Spring 2013 FORCE Newsletter with information on the status of PARP inhibitor research.

BROCADE Study - A PARP inhibitor study for advanced breast cancer
Article from Spring 2013 FORCE Newsletter with information about the BROCADE Study, a PARP inhibitor clinical trial for people with advanced BRCA-associated breast cancer.

Treatment for Triple-Negative Breast Cancer
2010 FORCE webinar presented by Dr. Melinda Telli of Stanford, providing updates on research specific to triple-negative breast cancer.

Clinical Trials
FORCE page with Information about participating in research and clinical trials including protections for patients who participate.

PARP Inhibitor Research Studies
FORCE listing and links to PARP inhibitor research studies enrolling patients with hereditary cancer.


Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.

Privacy Policy | Sitemap | Contact Us

Morphtek

This site has been made possible by a generous grant from Morphotek.


Web design by Rareheron Web Design

copyright © FORCE: Facing Our Risk of Cancer Empowered, Inc.  •  info@facingourrisk.org